Letter
Lipodermatosclerosis: Improvement noted with hydroxychloroquine and pentoxifylline

https://doi.org/10.1016/j.jaad.2011.11.942Get rights and content

References (5)

There are more references available in the full text version of this article.

Cited by (10)

  • Specific management of lipodermatosclerosis (sclerotic hypodermitis) in acute and chronic phase

    2022, JMV-Journal de Medecine Vasculaire
    Citation Excerpt :

    Choonhakarn and al published a retrospective study of 36 patients with lipodermatosclerosis treated with a combination of hydroxychloroquine and pentoxyfilline. Pain, erythema and edema were reduced in about 90% of cases and skin induration was reduced by half in 50% of cases [17]. Local application of capsaicin can reduce pain in the acute phase, with a prolonged effect [18].

  • May-Thurner syndrome in a case of severe lipodermatosclerosis

    2020, JAAD Case Reports
    Citation Excerpt :

    Management of LDS is similar to that of chronic venous insufficiency and involves compression therapy and leg elevation. Oral agents such as pentoxifylline, hydroxychloroquine, and others are also found to be helpful in some cases.3 May-Thurner syndrome (MTS) is a common but underdiagnosed condition in which the left common iliac vein is compressed between the overlying right common iliac artery and the lumbar vertebrae.

  • Unconventional uses of common conventional drugs: A review

    2021, Indian Journal of Dermatology, Venereology and Leprology
View all citing articles on Scopus

Funding sources: None.

Conflicts of interest: None declared.

View full text